Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Stapedial reflex threshold predicts individual loudness tolerance for people with autistic spectrum disorders.

Ohmura Y, Ichikawa I, Kumagaya S, Kuniyoshi Y.

Exp Brain Res. 2019 Jan;237(1):91-100. doi: 10.1007/s00221-018-5400-6. Epub 2018 Oct 11.

2.

Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.

Ichikawa I, Clayton EW.

Account Res. 2016;23(4):245-53. doi: 10.1080/08989621.2016.1144478. No abstract available.

3.

Genome-wide association study of IgA nephropathy using 23‚ÄČ465 microsatellite markers in a Japanese population.

Saka S, Hirawa N, Oka A, Yatsu K, Hirukawa T, Yamamoto R, Matsusaka T, Imai E, Narita I, Endoh M, Ichikawa I, Umemura S, Inoko H.

J Hum Genet. 2015 Oct;60(10):573-80. doi: 10.1038/jhg.2015.88. Epub 2015 Jul 23.

PMID:
26202575
4.

Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.

Okabe M, Miyazaki Y, Niimura F, Pastan I, Nishiyama A, Yokoo T, Ichikawa I, Matsusaka T.

Am J Physiol Renal Physiol. 2015 Apr 15;308(8):F932-7. doi: 10.1152/ajprenal.00444.2014. Epub 2015 Feb 11.

5.

Authorship guidelines and actual practice: are they harmonized in different research systems?

Vasconcelos S, Vasgird D, Ichikawa I, Plemmons D.

J Microbiol Biol Educ. 2014 Dec 15;15(2):155-8. doi: 10.1128/jmbe.v15i2.867. eCollection 2014 Dec. No abstract available.

6.

Kidney Diseases Enhance Expression of Tetraspanin-8: A Possible Protective Effect against Tubular Injury.

Hirukawa T, Wu Q, Sawada K, Matsusaka T, Saka S, Oka A, Hirawa N, Umemura S, Kakuta T, Endoh M, Inoko H, Ichikawa I, Fukagawa M.

Nephron Extra. 2014 Apr 30;4(1):70-81. doi: 10.1159/000362451. eCollection 2014 Jan.

7.

Mice are unable to endogenously regenerate podocytes during the repair of immunotoxin-induced glomerular injury.

Miyazaki Y, Shimizu A, Ichikawa I, Hosoya T, Pastan I, Matsusaka T.

Nephrol Dial Transplant. 2014 May;29(5):1005-12. doi: 10.1093/ndt/gft413. Epub 2013 Dec 8.

PMID:
24322577
8.

Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.

Matsusaka T, Niimura F, Pastan I, Shintani A, Nishiyama A, Ichikawa I.

Kidney Int. 2014 May;85(5):1068-77. doi: 10.1038/ki.2013.453. Epub 2013 Nov 27.

9.

Foxc1 gene null mutation causes ectopic budding and kidney hypoplasia but not dysplasia.

Komaki F, Miyazaki Y, Niimura F, Matsusaka T, Ichikawa I, Motojima M.

Cells Tissues Organs. 2013;198(1):22-7. doi: 10.1159/000351291. Epub 2013 Jul 3.

PMID:
23838094
10.

Maturational regression of glomeruli determines the nephron population in normal mice.

Zhong J, Perrien DS, Yang HC, Kon V, Fogo AB, Ichikawa I, Ma J.

Pediatr Res. 2012 Sep;72(3):241-8. doi: 10.1038/pr.2012.81. Epub 2012 Jun 20. Erratum in: Pediatr Res. 2014 Jun;75(6):803.

11.

Liver angiotensinogen is the primary source of renal angiotensin II.

Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I.

J Am Soc Nephrol. 2012 Jul;23(7):1181-9. doi: 10.1681/ASN.2011121159. Epub 2012 Apr 19.

12.

Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis.

Takagi N, Tanizawa T, Kon V, Fogo AB, Ichikawa I, Ma J.

Nephron Extra. 2012 Jan;2(1):17-26. doi: 10.1159/000334961. Epub 2012 Jan 31.

13.

ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.

Shimizu A, Zhong J, Miyazaki Y, Hosoya T, Ichikawa I, Matsusaka T.

Nephrol Dial Transplant. 2012 Aug;27(8):3169-75. doi: 10.1093/ndt/gfs033. Epub 2012 Mar 15.

14.

Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.

Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2856-64. doi: 10.1161/ATVBAHA.111.237198. Epub 2011 Oct 6.

15.

Podocyte injury damages other podocytes.

Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, Ichikawa I.

J Am Soc Nephrol. 2011 Jul;22(7):1275-85. doi: 10.1681/ASN.2010090963. Epub 2011 Jun 30.

16.

Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.

Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I.

Pediatr Res. 2011 Jul;70(1):83-9. doi: 10.1203/PDR.0b013e31821bdf1c.

17.

Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.

Yamamoto S, Zuo Y, Ma J, Yancey PG, Hunley TE, Motojima M, Fogo AB, Linton MF, Fazio S, Ichikawa I, Kon V.

Nephrol Dial Transplant. 2011 Aug;26(8):2491-7. doi: 10.1093/ndt/gfq759. Epub 2011 Jan 18.

18.

Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection.

Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo AB, Ichikawa I.

Am J Physiol Renal Physiol. 2011 Mar;300(3):F792-800. doi: 10.1152/ajprenal.00570.2010. Epub 2010 Dec 22.

19.

Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.

Matsusaka T, Asano T, Niimura F, Kinomura M, Shimizu A, Shintani A, Pastan I, Fogo AB, Ichikawa I.

Hypertension. 2010 Apr;55(4):967-73. doi: 10.1161/HYPERTENSIONAHA.109.141994. Epub 2010 Feb 8.

20.

Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro.

Motojima M, Matsusaka T, Kon V, Ichikawa I.

Nephron Exp Nephrol. 2010;114(2):e39-47. doi: 10.1159/000254390. Epub 2009 Nov 3.

21.

Renal dysfunction potentiates foam cell formation by repressing ABCA1.

Zuo Y, Yancey P, Castro I, Khan WN, Motojima M, Ichikawa I, Fogo AB, Linton MF, Fazio S, Kon V.

Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1277-82. doi: 10.1161/ATVBAHA.109.188995. Epub 2009 Aug 10. Erratum in: Arterioscler Thromb Vasc Biol. 2009 Dec 1;29(12):e133. Khan, Wasif [corrected to Khan, Wasif N].

22.

Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.

Suzuki T, Matsusaka T, Nakayama M, Asano T, Watanabe T, Ichikawa I, Nagata M.

Am J Pathol. 2009 May;174(5):1675-82. doi: 10.2353/ajpath.2009.080789. Epub 2009 Apr 9. Erratum in: Am J Pathol. 2009 Sep;175(3):1349.

23.

An essential role of the universal polarity protein, aPKClambda, on the maintenance of podocyte slit diaphragms.

Hirose T, Satoh D, Kurihara H, Kusaka C, Hirose H, Akimoto K, Matsusaka T, Ichikawa I, Noda T, Ohno S.

PLoS One. 2009;4(1):e4194. doi: 10.1371/journal.pone.0004194. Epub 2009 Jan 14.

24.

Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria.

Motoyoshi Y, Matsusaka T, Saito A, Pastan I, Willnow TE, Mizutani S, Ichikawa I.

Kidney Int. 2008 Nov;74(10):1262-9. doi: 10.1038/ki.2008.405. Epub 2008 Sep 3.

25.

Bmp in podocytes is essential for normal glomerular capillary formation.

Ueda H, Miyazaki Y, Matsusaka T, Utsunomiya Y, Kawamura T, Hosoya T, Ichikawa I.

J Am Soc Nephrol. 2008 Apr;19(4):685-94. doi: 10.1681/ASN.2006090983. Epub 2008 Feb 13.

26.

Effects of podocyte injury on glomerular development.

Ma J, Rossini M, Yang HC, Zuo Y, Fogo AB, Ichikawa I.

Pediatr Res. 2007 Oct;62(4):417-21.

PMID:
17667850
27.

Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.

Suganuma E, Babaev VR, Motojima M, Zuo Y, Ayabe N, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V.

J Am Soc Nephrol. 2007 Aug;18(8):2311-9. Epub 2007 Jul 18.

28.

HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.

Zuo Y, Matsusaka T, Zhong J, Ma J, Ma LJ, Hanna Z, Jolicoeur P, Fogo AB, Ichikawa I.

J Am Soc Nephrol. 2006 Oct;17(10):2832-43. Epub 2006 Sep 20.

29.

Inferior vena cava diameter pulse waveforms in the human fetus: relationship with flow velocity waveform.

Mori A, Uchida N, Inomo A, Izumi S, Ichikawa I.

J Perinat Med. 2006;34(5):414-9.

PMID:
16965230
30.

The renin-angiotensin system in the development of the congenital anomalies of the kidney and urinary tract.

Niimura F, Kon V, Ichikawa I.

Curr Opin Pediatr. 2006 Apr;18(2):161-6. Review.

PMID:
16601496
31.

Inhibition of endogenous BMP in the glomerulus leads to mesangial matrix expansion.

Miyazaki Y, Ueda H, Yokoo T, Utsunomiya Y, Kawamura T, Matsusaka T, Ichikawa I, Hosoya T.

Biochem Biophys Res Commun. 2006 Feb 10;340(2):681-8. Epub 2005 Dec 20.

PMID:
16389070
32.

Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.

Suganuma E, Zuo Y, Ayabe N, Ma J, Babaev VR, Linton MF, Fazio S, Ichikawa I, Fogo AB, Kon V.

J Am Soc Nephrol. 2006 Feb;17(2):433-41. Epub 2005 Dec 21.

33.

Rapid downregulation of beta-actin-based CAG promoter and filamentous actin in injured podocytes.

Asano T, Matsusaka T, Mizutani S, Ichikawa I.

J Med Dent Sci. 2005 Jun;52(2):129-34.

PMID:
16189885
34.

Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.

Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T.

Kidney Int. 2005 Sep;68(3):1048-60.

35.

Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice.

Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V.

Atherosclerosis. 2006 Feb;184(2):312-21. Epub 2005 Jul 14.

PMID:
16023123
36.

Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.

Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T.

J Am Soc Nephrol. 2005 Aug;16(8):2257-62. Epub 2005 Jun 29.

37.

Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis.

Ichikawa I, Ma J, Motojima M, Matsusaka T.

Curr Opin Nephrol Hypertens. 2005 May;14(3):205-10. Review.

PMID:
15821411
38.

Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.

Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I.

J Am Soc Nephrol. 2005 Apr;16(4):1013-23. Epub 2005 Mar 9.

39.

[Clinical pathway based on evidence-based medicine (EBM) for chemotherapy for lung cancer].

Kogo M, Saito Y, Kashiwabara Y, Koichi K, Ichikawa I, Horichi N, Imai T, Adachi M, Murayama J, Kiuchi Y.

Yakugaku Zasshi. 2004 Dec;124(12):973-81. Japanese.

40.

Angiotensin II amplifies macrophage-driven atherosclerosis.

Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V.

Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2143-8. Epub 2004 Sep 16.

PMID:
15374850
41.

Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein.

Xin J, Homma T, Matsusaka T, Ma J, Isaka Y, Imai E, Ichikawa I.

Transplantation. 2004 May 15;77(9):1433-42.

PMID:
15167603
42.

Local actions of endogenous angiotensin II in injured glomeruli.

Ma J, Matsusaka T, Yang H, Kawachi H, Shimizu F, Isaka Y, Imai E, Kon V, Ichikawa I.

J Am Soc Nephrol. 2004 May;15(5):1268-76.

43.

Screening for mutations in BMP4 and FOXC1 genes in congenital anomalies of the kidney and urinary tract in humans.

Nakano T, Niimura F, Hohenfellner K, Miyakita E, Ichikawa I.

Tokai J Exp Clin Med. 2003 Oct;28(3):121-6.

PMID:
15055404
44.

Ontogeny of congenital anomalies of the kidney and urinary tract, CAKUT.

Miyazaki Y, Ichikawa I.

Pediatr Int. 2003 Oct;45(5):598-604.

PMID:
14521544
45.

Recurrent postictal psychosis after remission of interictal psychosis: further evidence of bimodal psychosis.

Adachi N, Kato M, Sekimoto M, Ichikawa I, Akanuma N, Uesugi H, Matsuda H, Ishida S, Onuma T.

Epilepsia. 2003 Sep;44(9):1218-22.

46.

Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.

Nomura M, Kuno-Sakai H, Kimura M, Ichikawa I.

Tokai J Exp Clin Med. 2003 Apr;28(1):21-6. No abstract available.

PMID:
12880300
47.
48.

Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I.

J Clin Invest. 2002 Dec;110(12):1859-68.

49.

Embryogenesis of the congenital anomalies of the kidney and the urinary tract.

Kuwayama F, Miyazaki Y, Ichikawa I.

Nephrol Dial Transplant. 2002;17 Suppl 9:45-7.

PMID:
12386286
50.

[History of nephrology in the past 100 years: Significance of hyperfiltration theory in the nephrology].

Yoshida H, Ichikawa I.

Nihon Naika Gakkai Zasshi. 2002 May 10;91(5):1405-8. Review. Japanese. No abstract available.

PMID:
12082723

Supplemental Content

Loading ...
Support Center